25 XP   0   0   10

Lanzhou Foci Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Lanzhou Foci Pharmaceutical Co Ltd together

PenkeI guess you are interested in Lanzhou Foci Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lanzhou Foci Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lanzhou Foci Pharmaceutical Co Ltd

I send you an email if I find something interesting about Lanzhou Foci Pharmaceutical Co Ltd.

Quick analysis of Lanzhou Foci Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Lanzhou Foci Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
77.5%

What is your share worth?

Current worth
¥3.50
Expected worth in 1 year
¥3.55
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥0.05
Return On Investment
0.7%

For what price can you sell your share?

Current Price per Share
¥7.28
Expected price per share
¥5.84 - ¥8.22
How sure are you?
50%

1. Valuation of Lanzhou Foci Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥7.28

Intrinsic Value Per Share

¥-3.22 - ¥-3.88

Total Value Per Share

¥0.28 - ¥-0.38

2. Growth of Lanzhou Foci Pharmaceutical Co Ltd (5 min.)




Is Lanzhou Foci Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$246.7m$236.6m$8.1m3.3%

How much money is Lanzhou Foci Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2m$3.8m-$1.8m-92.5%
Net Profit Margin5.0%9.8%--

How much money comes from the company's main activities?

3. Financial Health of Lanzhou Foci Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Lanzhou Foci Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Lanzhou Foci Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Lanzhou Foci Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Lanzhou Foci Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Lanzhou Foci Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Lanzhou Foci Pharmaceutical Co Ltd is ¥7.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lanzhou Foci Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lanzhou Foci Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.50. Based on the TTM, the Book Value Change Per Share is ¥0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lanzhou Foci Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.1%0.000.1%0.010.1%0.010.1%0.000.1%
Usd Book Value Change Per Share0.010.1%0.000.0%0.010.1%0.000.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.000.0%
Usd Total Gains Per Share0.010.1%0.000.0%0.010.1%0.010.1%0.010.1%
Usd Price Per Share1.11-1.43-1.36-1.23-1.65-
Price to Earnings Ratio55.82-241.01-209.23-152.16-158.77-
Price-to-Total Gains Ratio220.24-1,718.74-541.02-532.63-492.56-
Price to Book Ratio2.30-2.98-2.92-2.76-4.83-
Price-to-Total Gains Ratio220.24-1,718.74-541.02-532.63-492.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.005368
Number of shares994
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.01
Gains per Quarter (994 shares)1.809.39
Gains per Year (994 shares)7.2137.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
107-3201828
21144393666
3120115954104
4227187972142
5234259890180
634132118107218
734739138125256
845446157143294
946153177161332
1046860197179370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%51.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%50.01.00.098.0%
Dividend per Share1.00.03.025.0%8.00.04.066.7%15.00.05.075.0%31.00.09.077.5%42.00.09.082.4%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%51.00.00.0100.0%

Fundamentals of Lanzhou Foci Pharmaceutical Co Ltd

About Lanzhou Foci Pharmaceutical Co Ltd

LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional chinese medicines in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gel under the Min Shan and Foci brands. It also engages in research and development of new herbal drugs. In addition, the company exports its products worldwide. The company was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd.

Fundamental data was last updated by Penke on 2024-04-14 18:30:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lanzhou Foci Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lanzhou Foci Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.7% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 6.7%. The company is making a profit. +1
  • The TTM is 5.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.7%TTM5.0%+1.7%
TTM5.0%YOY9.8%-4.8%
TTM5.0%5Y11.0%-6.0%
5Y11.0%10Y12.2%-1.3%
1.1.2. Return on Assets

Shows how efficient Lanzhou Foci Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.7% Return on Assets means that Lanzhou Foci Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.6%+0.2%
TTM0.6%YOY1.1%-0.5%
TTM0.6%5Y0.9%-0.4%
5Y0.9%10Y0.9%+0.1%
1.1.3. Return on Equity

Shows how efficient Lanzhou Foci Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.0% Return on Equity means Lanzhou Foci Pharmaceutical Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 1.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM0.8%+0.2%
TTM0.8%YOY1.6%-0.8%
TTM0.8%5Y1.4%-0.6%
5Y1.4%10Y1.3%+0.1%

1.2. Operating Efficiency of Lanzhou Foci Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lanzhou Foci Pharmaceutical Co Ltd is operating .

  • Measures how much profit Lanzhou Foci Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.8%-3.8%
TTM3.8%YOY5.4%-1.6%
TTM3.8%5Y6.8%-3.0%
5Y6.8%10Y3.9%+2.9%
1.2.2. Operating Ratio

Measures how efficient Lanzhou Foci Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.57 means that the operating costs are ¥1.57 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 1.568. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.593. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.568TTM1.593-0.025
TTM1.593YOY1.589+0.004
TTM1.5935Y1.607-0.014
5Y1.60710Y1.214+0.393

1.3. Liquidity of Lanzhou Foci Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lanzhou Foci Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.71 means the company has ¥2.71 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 2.709. The company is able to pay all its short-term debts. +1
  • The TTM is 2.598. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.709TTM2.598+0.112
TTM2.598YOY2.492+0.105
TTM2.5985Y2.599-0.001
5Y2.59910Y1.473+1.125
1.3.2. Quick Ratio

Measures if Lanzhou Foci Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.78 means the company can pay off ¥0.78 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 0.778. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.849. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.778TTM0.849-0.071
TTM0.849YOY0.862-0.013
TTM0.8495Y0.844+0.005
5Y0.84410Y0.895-0.051

1.4. Solvency of Lanzhou Foci Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lanzhou Foci Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.29 means that Lanzhou Foci Pharmaceutical Co Ltd assets are financed with 29.3% credit (debt) and the remaining percentage (100% - 29.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 0.293. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.306. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.293TTM0.306-0.013
TTM0.306YOY0.323-0.017
TTM0.3065Y0.325-0.019
5Y0.32510Y0.320+0.005
1.4.2. Debt to Equity Ratio

Measures if Lanzhou Foci Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 42.0% means that company has ¥0.42 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The MRQ is 0.420. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.446. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.420TTM0.446-0.027
TTM0.446YOY0.482-0.036
TTM0.4465Y0.487-0.041
5Y0.48710Y0.486+0.000

2. Market Valuation of Lanzhou Foci Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Lanzhou Foci Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Lanzhou Foci Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 55.82 means the investor is paying ¥55.82 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The EOD is 50.546. Based on the earnings, the company is expensive. -2
  • The MRQ is 55.822. Based on the earnings, the company is expensive. -2
  • The TTM is 241.013. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD50.546MRQ55.822-5.277
MRQ55.822TTM241.013-185.190
TTM241.013YOY209.230+31.782
TTM241.0135Y152.160+88.852
5Y152.16010Y158.773-6.613
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The EOD is -51.163. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -56.504. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -105.156. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-51.163MRQ-56.504+5.341
MRQ-56.504TTM-105.156+48.651
TTM-105.156YOY37.881-143.036
TTM-105.1565Y35.561-140.717
5Y35.56110Y88.067-52.505
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lanzhou Foci Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Lanzhou Foci Pharmaceutical Co Ltd:

  • The EOD is 2.080. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.297. Based on the equity, the company is underpriced. +1
  • The TTM is 2.980. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.080MRQ2.297-0.217
MRQ2.297TTM2.980-0.682
TTM2.980YOY2.921+0.058
TTM2.9805Y2.762+0.218
5Y2.76210Y4.832-2.070
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lanzhou Foci Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0370.012+196%0.058-37%0.033+12%0.053-31%
Book Value Per Share--3.5003.471+1%3.356+4%3.214+9%2.808+25%
Current Ratio--2.7092.598+4%2.492+9%2.599+4%1.473+84%
Debt To Asset Ratio--0.2930.306-4%0.323-9%0.325-10%0.320-8%
Debt To Equity Ratio--0.4200.446-6%0.482-13%0.487-14%0.486-14%
Dividend Per Share---0.001-100%0.003-100%0.036-100%0.022-100%
Eps--0.0360.028+27%0.042-15%0.042-15%0.036+1%
Free Cash Flow Per Share---0.0360.023-255%-0.008-78%-0.002-94%-0.056+59%
Free Cash Flow To Equity Per Share---0.0360.018-297%-0.030-15%-0.021-42%0.043-183%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---3.880--------
Intrinsic Value_10Y_min---3.216--------
Intrinsic Value_1Y_max---0.047--------
Intrinsic Value_1Y_min---0.046--------
Intrinsic Value_3Y_max---0.401--------
Intrinsic Value_3Y_min---0.378--------
Intrinsic Value_5Y_max---1.070--------
Intrinsic Value_5Y_min---0.971--------
Market Cap3717582901.760-10%4105682280.0005277640095.000-22%5010821812.500-18%4550719850.124-10%6110324330.240-33%
Net Profit Margin--0.0670.050+34%0.098-32%0.110-39%0.122-45%
Operating Margin---0.038-100%0.054-100%0.068-100%0.039-100%
Operating Ratio--1.5681.593-2%1.589-1%1.607-2%1.214+29%
Pb Ratio2.080-10%2.2972.980-23%2.921-21%2.762-17%4.832-52%
Pe Ratio50.546-10%55.822241.013-77%209.230-73%152.160-63%158.773-65%
Price Per Share7.280-10%8.04010.335-22%9.813-18%8.912-10%11.966-33%
Price To Free Cash Flow Ratio-51.163+9%-56.504-105.156+86%37.881-249%35.561-259%88.067-164%
Price To Total Gains Ratio199.424-10%220.2431718.744-87%541.016-59%532.630-59%492.560-55%
Quick Ratio--0.7780.849-8%0.862-10%0.844-8%0.895-13%
Return On Assets--0.0070.006+28%0.011-33%0.009-23%0.009-17%
Return On Equity--0.0100.008+26%0.016-36%0.014-27%0.013-21%
Total Gains Per Share--0.0370.013+178%0.061-40%0.068-47%0.075-51%
Usd Book Value--246794575.622244759671.161+1%236637256.758+4%226656874.147+9%198002430.557+25%
Usd Book Value Change Per Share--0.0050.002+196%0.008-37%0.005+12%0.007-31%
Usd Book Value Per Share--0.4830.479+1%0.463+4%0.444+9%0.388+25%
Usd Dividend Per Share---0.000-100%0.000-100%0.005-100%0.003-100%
Usd Eps--0.0050.004+27%0.006-15%0.006-15%0.005+1%
Usd Free Cash Flow---2508645.9481616126.364-255%-560511.563-78%-139149.526-94%-3784084.988+51%
Usd Free Cash Flow Per Share---0.0050.003-255%-0.001-78%0.000-94%-0.008+59%
Usd Free Cash Flow To Equity Per Share---0.0050.002-297%-0.004-15%-0.003-42%0.006-183%
Usd Market Cap513398198.733-10%566994722.868728842097.120-22%691994492.306-18%628454411.302-10%843835790.006-33%
Usd Price Per Share1.005-10%1.1101.427-22%1.355-18%1.231-10%1.652-33%
Usd Profit--2539275.6722006675.938+27%3863481.938-34%3187253.388-20%2610296.585-3%
Usd Revenue--37884904.49839015634.265-3%37621624.081+1%30486335.862+24%22816596.227+66%
Usd Total Gains Per Share--0.0050.002+178%0.008-40%0.009-47%0.010-51%
 EOD+3 -5MRQTTM+20 -15YOY+12 -235Y+14 -2110Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Lanzhou Foci Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1550.546
Price to Book Ratio (EOD)Between0-12.080
Net Profit Margin (MRQ)Greater than00.067
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.778
Current Ratio (MRQ)Greater than12.709
Debt to Asset Ratio (MRQ)Less than10.293
Debt to Equity Ratio (MRQ)Less than10.420
Return on Equity (MRQ)Greater than0.150.010
Return on Assets (MRQ)Greater than0.050.007
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Lanzhou Foci Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.173
Ma 20Greater thanMa 507.696
Ma 50Greater thanMa 1007.645
Ma 100Greater thanMa 2008.542
OpenGreater thanClose7.150
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,527,502
Total Liabilities740,431
Total Stockholder Equity1,763,758
 As reported
Total Liabilities 740,431
Total Stockholder Equity+ 1,763,758
Total Assets = 2,527,502

Assets

Total Assets2,527,502
Total Current Assets1,252,845
Long-term Assets1,274,657
Total Current Assets
Cash And Cash Equivalents 365,339
Net Receivables 359,773
Inventory 379,869
Other Current Assets 19,282
Total Current Assets  (as reported)1,252,845
Total Current Assets  (calculated)1,124,263
+/- 128,582
Long-term Assets
Property Plant Equipment 1,047,269
Goodwill 9,010
Intangible Assets 79,318
Long-term Assets Other 7,505
Long-term Assets  (as reported)1,274,657
Long-term Assets  (calculated)1,143,101
+/- 131,556

Liabilities & Shareholders' Equity

Total Current Liabilities462,404
Long-term Liabilities278,027
Total Stockholder Equity1,763,758
Total Current Liabilities
Short Long Term Debt 10,000
Accounts payable 304,539
Other Current Liabilities 5,768
Total Current Liabilities  (as reported)462,404
Total Current Liabilities  (calculated)320,307
+/- 142,097
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,391
Long-term Liabilities  (as reported)278,027
Long-term Liabilities  (calculated)1,391
+/- 276,636
Total Stockholder Equity
Retained Earnings 794,585
Total Stockholder Equity (as reported)1,763,758
Total Stockholder Equity (calculated)794,585
+/- 969,173
Other
Capital Stock510,657
Common Stock Shares Outstanding 510,657
Net Invested Capital 1,773,758
Net Working Capital 790,441
Property Plant and Equipment Gross 1,047,269



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302010-12-312009-12-312008-12-31
> Total Assets 
400,517
422,050
456,162
500,040
502,593
829,229
782,999
781,281
784,191
822,914
807,387
814,619
888,868
903,078
1,056,485
1,010,774
1,010,678
1,046,618
1,491,929
1,524,561
1,501,829
1,362,419
1,638,126
1,694,599
1,743,591
2,036,714
2,071,811
2,153,285
2,198,332
2,349,825
2,319,393
2,332,824
2,366,573
2,521,392
2,459,926
2,425,898
2,437,956
2,314,892
2,357,476
2,360,651
2,301,345
2,267,133
2,301,219
2,359,952
2,358,823
2,352,094
2,455,176
2,455,784
2,385,128
2,586,569
2,707,397
2,597,702
2,562,119
2,528,102
2,527,502
2,527,5022,528,1022,562,1192,597,7022,707,3972,586,5692,385,1282,455,7842,455,1762,352,0942,358,8232,359,9522,301,2192,267,1332,301,3452,360,6512,357,4762,314,8922,437,9562,425,8982,459,9262,521,3922,366,5732,332,8242,319,3932,349,8252,198,3322,153,2852,071,8112,036,7141,743,5911,694,5991,638,1261,362,4191,501,8291,524,5611,491,9291,046,6181,010,6781,010,7741,056,485903,078888,868814,619807,387822,914784,191781,281782,999829,229502,593500,040456,162422,050400,517
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
983,189
926,527
904,221
1,021,232
999,353
1,036,342
1,086,724
1,126,499
1,081,034
1,054,148
1,093,386
1,160,276
1,173,169
1,034,632
1,115,190
1,147,746
1,070,387
1,291,068
1,416,547
1,297,426
1,271,080
1,238,869
1,252,845
1,252,8451,238,8691,271,0801,297,4261,416,5471,291,0681,070,3871,147,7461,115,1901,034,6321,173,1691,160,2761,093,3861,054,1481,081,0341,126,4991,086,7241,036,342999,3531,021,232904,221926,527983,18900000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
361,729
465,549
351,307
426,107
407,886
434,654
425,205
407,035
374,101
419,961
381,859
390,260
324,714
374,940
385,179
383,820
278,719
396,453
362,262
336,080
305,732
406,041
365,339
365,339406,041305,732336,080362,262396,453278,719383,820385,179374,940324,714390,260381,859419,961374,101407,035425,205434,654407,886426,107351,307465,549361,72900000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,900
0
0
0
0
0
0
0
32,080
68,080
64,000
28,000
0
0
0
0
2,002
0
0
0
0
0
000002,002000028,00064,00068,08032,08000000002,900000000000000000000000000000000000
       Net Receivables 
75,458
101,640
68,297
80,310
70,213
93,227
112,396
146,376
136,415
123,211
153,035
170,059
207,691
181,592
176,121
152,323
137,890
143,167
153,555
158,643
152,848
119,358
116,841
110,466
98,891
89,314
113,642
111,910
121,924
137,394
190,882
197,820
204,261
183,196
193,140
185,323
228,462
268,441
281,926
359,445
390,034
317,892
353,236
347,315
443,068
357,142
380,694
349,389
413,033
389,571
553,066
495,380
528,308
285,488
359,773
359,773285,488528,308495,380553,066389,571413,033349,389380,694357,142443,068347,315353,236317,892390,034359,445281,926268,441228,462185,323193,140183,196204,261197,820190,882137,394121,924111,910113,64289,31498,891110,466116,841119,358152,848158,643153,555143,167137,890152,323176,121181,592207,691170,059153,035123,211136,415146,376112,39693,22770,21380,31068,297101,64075,458
       Other Current Assets 
742
6,852
5,093
9,600
6,901
949
5,480
6,507
4,241
4,249
4,943
4,018
3,771
52,592
53,922
54,617
61,026
12,284
14,406
22,848
25,653
11,398
523,974
16,747
503,945
28,306
634,339
36,364
738,891
35,963
575,519
57,127
194,236
33,558
56,906
4,485
3,199
46,433
47,922
18,955
19,664
25,889
50,052
77,963
92,058
43,719
57,602
58,610
89,867
15,663
82,275
15,960
57,328
21,297
19,282
19,28221,29757,32815,96082,27515,66389,86758,61057,60243,71992,05877,96350,05225,88919,66418,95547,92246,4333,1994,48556,90633,558194,23657,127575,51935,963738,89136,364634,33928,306503,94516,747523,97411,39825,65322,84814,40612,28461,02654,61753,92252,5923,7714,0184,9434,2494,2416,5075,4809496,9019,6005,0936,852742
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,555,705
1,404,666
1,438,603
1,278,551
1,270,752
1,234,153
1,220,311
1,212,984
1,207,833
1,199,676
1,185,654
1,317,461
1,339,986
1,308,038
1,314,741
1,295,501
1,290,850
1,300,276
1,291,040
1,289,233
1,274,657
1,274,6571,289,2331,291,0401,300,2761,290,8501,295,5011,314,7411,308,0381,339,9861,317,4611,185,6541,199,6761,207,8331,212,9841,220,3111,234,1531,270,7521,278,5511,438,6031,404,6661,555,7050000000000000000000000000000000000
       Property Plant Equipment 
136,037
137,041
151,686
260,871
197,339
183,164
188,619
202,172
254,824
267,764
268,533
268,251
267,876
294,125
296,042
297,751
292,515
167,042
165,445
162,536
164,530
187,776
182,846
299,826
408,008
471,217
521,820
669,449
801,187
1,099,982
1,146,087
1,186,397
1,227,983
1,223,034
1,253,598
1,091,625
1,146,559
971,630
959,207
961,114
953,071
956,378
947,949
945,723
964,367
1,091,607
1,124,585
1,082,913
1,078,751
1,066,800
1,051,162
1,058,538
1,044,296
1,061,836
1,047,269
1,047,2691,061,8361,044,2961,058,5381,051,1621,066,8001,078,7511,082,9131,124,5851,091,607964,367945,723947,949956,378953,071961,114959,207971,6301,146,5591,091,6251,253,5981,223,0341,227,9831,186,3971,146,0871,099,982801,187669,449521,820471,217408,008299,826182,846187,776164,530162,536165,445167,042292,515297,751296,042294,125267,876268,251268,533267,764254,824202,172188,619183,164197,339260,871151,686137,041136,037
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
4,472
9,010
9,010
9,0109,0104,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4720000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,500
42,500
20,000
80,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000080,30020,00042,50042,500000000000000000000000000000000000
       Intangible Assets 
101,260
74,151
71,923
85,750
85,236
84,725
84,213
83,702
83,190
85,437
84,925
84,367
83,832
84,517
83,982
72,679
72,174
147,877
146,981
104,916
104,327
120,264
119,573
119,266
118,649
118,699
117,979
117,262
128,396
127,588
126,822
126,185
125,420
124,776
123,978
2,171
108,268
75,831
75,340
74,849
74,358
74,013
73,522
73,074
72,619
71,963
71,435
79,182
79,207
76,789
76,089
81,292
80,501
79,551
79,318
79,31879,55180,50181,29276,08976,78979,20779,18271,43571,96372,61973,07473,52274,01374,35874,84975,34075,831108,2682,171123,978124,776125,420126,185126,822127,588128,396117,262117,979118,699118,649119,266119,573120,264104,327104,916146,981147,87772,17472,67983,98284,51783,83284,36784,92585,43783,19083,70284,21384,72585,23685,75071,92374,151101,260
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125,636
105,058
92,918
84,580
91,071
49,113
1,000,988
42,073
46,596
41,305
7,700
16,225
11,059
6,960
15,401
11,876
24,536
17,356
24,062
5,313
7,505
7,5055,31324,06217,35624,53611,87615,4016,96011,05916,2257,70041,30546,59642,0731,000,98849,11391,07184,58092,918105,058125,6360000000000000000000000000000000000
> Total Liabilities 
183,705
169,090
129,699
158,626
151,456
181,144
130,255
123,305
118,771
147,382
126,908
128,113
192,121
199,704
347,709
294,168
282,256
311,399
292,124
314,924
278,195
128,766
395,086
434,917
467,375
746,131
767,529
827,896
861,606
990,677
937,869
937,624
956,476
1,079,604
1,005,160
946,236
929,820
802,875
837,824
781,789
708,664
670,964
677,665
772,293
746,849
724,593
811,436
777,591
705,119
852,596
945,488
831,871
794,106
759,672
740,431
740,431759,672794,106831,871945,488852,596705,119777,591811,436724,593746,849772,293677,665670,964708,664781,789837,824802,875929,820946,2361,005,1601,079,604956,476937,624937,869990,677861,606827,896767,529746,131467,375434,917395,086128,766278,195314,924292,124311,399282,256294,168347,709199,704192,121128,113126,908147,382118,771123,305130,255181,144151,456158,626129,699169,090183,705
   > Total Current Liabilities 
173,131
158,063
116,299
145,226
137,856
167,546
116,657
110,255
105,721
132,710
112,236
113,714
162,722
160,802
150,116
97,123
85,426
114,044
95,235
118,294
82,890
87,555
86,117
126,575
156,180
136,164
157,240
211,732
233,358
370,920
317,291
318,056
336,587
491,161
419,689
399,456
393,062
440,900
495,497
441,585
372,448
338,863
361,348
459,769
423,596
374,839
479,085
450,899
384,400
530,486
642,309
526,893
494,567
467,688
462,404
462,404467,688494,567526,893642,309530,486384,400450,899479,085374,839423,596459,769361,348338,863372,448441,585495,497440,900393,062399,456419,689491,161336,587318,056317,291370,920233,358211,732157,240136,164156,180126,57586,11787,55582,890118,29495,235114,04485,42697,123150,116160,802162,722113,714112,236132,710105,721110,255116,657167,546137,856145,226116,299158,063173,131
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,252
0
14,523
14,523
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000014,52314,523017,252000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,252
0
14,523
14,523
0
9,283
19,361
19,361
19,622
10,601
0
0
0
0
0
0
0
0
10,000
10,000
10,000
10,000
10,00010,00010,00010,0000000000010,60119,62219,36119,3619,283014,52314,523017,252000000000000000000000000000000000
       Accounts payable 
42,617
38,597
29,535
51,068
31,982
58,303
25,818
17,910
18,369
43,920
17,066
18,290
12,893
15,170
24,641
39,722
43,463
63,373
44,105
69,891
41,148
52,716
52,348
96,718
127,371
104,091
115,198
173,181
191,559
323,715
264,201
290,384
294,452
435,451
378,255
354,654
331,376
334,798
355,237
313,681
238,631
221,571
238,274
277,902
297,133
214,299
314,612
304,443
261,360
311,045
442,268
355,955
367,785
310,373
304,539
304,539310,373367,785355,955442,268311,045261,360304,443314,612214,299297,133277,902238,274221,571238,631313,681355,237334,798331,376354,654378,255435,451294,452290,384264,201323,715191,559173,181115,198104,091127,37196,71852,34852,71641,14869,89144,10563,37343,46339,72224,64115,17012,89318,29017,06643,92018,36917,91025,81858,30331,98251,06829,53538,59742,617
       Other Current Liabilities 
71,514
73,466
40,764
23,158
29,874
33,243
14,839
16,345
11,352
12,790
19,170
19,424
25,829
21,632
21,476
27,401
21,962
24,671
29,129
31,403
26,742
34,840
33,769
29,857
28,808
32,073
42,042
38,551
41,798
47,205
53,090
27,673
37,866
31,377
39,171
14,523
14,523
88,460
108,472
88,739
93,466
73,332
86,395
153,497
109,386
135,941
140,806
118,113
99,964
8,241
197,987
142,632
99,641
5,842
5,768
5,7685,84299,641142,632197,9878,24199,964118,113140,806135,941109,386153,49786,39573,33293,46688,739108,47288,46014,52314,52339,17131,37737,86627,67353,09047,20541,79838,55142,04232,07328,80829,85733,76934,84026,74231,40329,12924,67121,96227,40121,47621,63225,82919,42419,17012,79011,35216,34514,83933,24329,87423,15840,76473,46671,514
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
585,471
546,780
536,758
361,975
342,327
340,204
336,216
332,101
316,317
312,524
323,254
349,754
332,351
326,692
320,719
322,109
303,179
304,977
299,539
291,985
278,027
278,027291,985299,539304,977303,179322,109320,719326,692332,351349,754323,254312,524316,317332,101336,216340,204342,327361,975536,758546,780585,4710000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-17,252
0
-14,523
-14,523
0
0
0
0
0
0
0
0
807
807
420
531
531
512
348
149
1,346
1,391
1,3911,34614934851253153142080780700000000-14,523-14,5230-17,252000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,137
0
67,138
0
39,585
0
0
0
0
0
0
0
0
0000000039,585067,138053,137000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
717
564
564
482
482
401
401
6,022
3,212
272
272
208
208
894
519
3,708
8,266
0
0
9,802
9,751
0
0
009,7519,802008,2663,7085198942082082722723,2126,02240140148248256456471700000000000000000000000000000000
> Total Stockholder Equity
216,813
252,960
326,463
341,414
351,137
648,084
652,743
657,976
665,420
675,532
680,479
686,507
696,746
703,374
708,776
716,606
728,421
735,220
1,199,805
1,209,638
1,223,634
1,233,653
1,243,040
1,259,682
1,276,215
1,290,583
1,304,282
1,325,389
1,336,726
1,359,148
1,381,524
1,395,199
1,410,097
1,441,788
1,454,766
1,479,662
1,508,136
1,510,002
1,517,713
1,576,914
1,587,507
1,591,160
1,615,248
1,579,494
1,603,608
1,614,577
1,630,767
1,665,092
1,666,746
1,715,390
1,742,844
1,746,936
1,748,997
1,745,371
1,763,758
1,763,7581,745,3711,748,9971,746,9361,742,8441,715,3901,666,7461,665,0921,630,7671,614,5771,603,6081,579,4941,615,2481,591,1601,587,5071,576,9141,517,7131,510,0021,508,1361,479,6621,454,7661,441,7881,410,0971,395,1991,381,5241,359,1481,336,7261,325,3891,304,2821,290,5831,276,2151,259,6821,243,0401,233,6531,223,6341,209,6381,199,805735,220728,421716,606708,776703,374696,746686,507680,479675,532665,420657,976652,743648,084351,137341,414326,463252,960216,813
   Common Stock
60,580
60,580
60,580
60,580
60,580
80,780
80,780
88,858
88,858
88,858
88,858
88,858
88,858
88,858
88,858
177,716
177,716
177,716
204,263
204,263
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
510,657
0
510,657
0
510,657
0
0
00510,6570510,6570510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657510,657204,263204,263177,716177,716177,71688,85888,85888,85888,85888,85888,85888,85888,85880,78080,78060,58060,58060,58060,58060,580
   Retained Earnings 
125,547
158,080
204,197
219,148
228,871
233,052
237,711
234,865
242,309
249,386
254,333
260,361
270,600
274,093
328,296
336,125
299,140
354,739
360,985
370,668
384,514
394,383
403,620
420,112
436,495
450,713
464,262
485,218
496,406
518,678
540,904
554,429
569,227
586,318
521,769
546,665
575,140
654,532
662,243
721,444
732,037
735,874
759,962
724,145
748,322
758,785
774,975
804,916
806,559
746,949
887,079
891,145
893,210
776,197
794,585
794,585776,197893,210891,145887,079746,949806,559804,916774,975758,785748,322724,145759,962735,874732,037721,444662,243654,532575,140546,665521,769586,318569,227554,429540,904518,678496,406485,218464,262450,713436,495420,112403,620394,383384,514370,668360,985354,739299,140336,125328,296274,093270,600260,361254,333249,386242,309234,865237,711233,052228,871219,148204,197158,080125,547
   Capital Surplus 0000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,200
1,800
1,800
1,800
1,800
1,800
1,800
1,800
1,800
1,616
1,616
1,679
1,616
1,624
1,624
1,638
1,649
0
1,597
1,624
1,618
0
0
001,6181,6241,59701,6491,6381,6241,6241,6161,6791,6161,6161,8001,8001,8001,8001,8001,8001,8001,8002,20000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,163,134
Cost of Revenue-801,839
Gross Profit361,296361,296
 
Operating Income (+$)
Gross Profit361,296
Operating Expense-1,063,803
Operating Income99,331-702,507
 
Operating Expense (+$)
Research Development30,927
Selling General Administrative172,840
Selling And Marketing Expenses0
Operating Expense1,063,803203,766
 
Net Interest Income (+$)
Interest Income5,369
Interest Expense-1,241
Other Finance Cost-233
Net Interest Income3,896
 
Pretax Income (+$)
Operating Income99,331
Net Interest Income3,896
Other Non-Operating Income Expenses0
Income Before Tax (EBT)81,64299,331
EBIT - interestExpense = -1,241
67,190
68,430
Interest Expense1,241
Earnings Before Interest and Taxes (EBIT)082,883
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax81,642
Tax Provision-13,520
Net Income From Continuing Ops68,12268,122
Net Income67,190
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-3,896
 

Technical Analysis of Lanzhou Foci Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lanzhou Foci Pharmaceutical Co Ltd. The general trend of Lanzhou Foci Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lanzhou Foci Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lanzhou Foci Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.39 < 7.7 < 8.22.

The bearish price targets are: 6.79 > 5.84.

Tweet this
Lanzhou Foci Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lanzhou Foci Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lanzhou Foci Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lanzhou Foci Pharmaceutical Co Ltd. The current macd is -0.21614539.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lanzhou Foci Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lanzhou Foci Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lanzhou Foci Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Lanzhou Foci Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLanzhou Foci Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lanzhou Foci Pharmaceutical Co Ltd. The current adx is 24.44.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lanzhou Foci Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Lanzhou Foci Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lanzhou Foci Pharmaceutical Co Ltd. The current sar is 7.43.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lanzhou Foci Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lanzhou Foci Pharmaceutical Co Ltd. The current rsi is 41.17. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Lanzhou Foci Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartLanzhou Foci Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lanzhou Foci Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lanzhou Foci Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lanzhou Foci Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartLanzhou Foci Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lanzhou Foci Pharmaceutical Co Ltd. The current cci is -91.57671645.

Lanzhou Foci Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartLanzhou Foci Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lanzhou Foci Pharmaceutical Co Ltd. The current cmo is -19.88028907.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lanzhou Foci Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartLanzhou Foci Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lanzhou Foci Pharmaceutical Co Ltd. The current willr is -65.73426573.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lanzhou Foci Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lanzhou Foci Pharmaceutical Co Ltd Daily Williams %R ChartLanzhou Foci Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lanzhou Foci Pharmaceutical Co Ltd.

Lanzhou Foci Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lanzhou Foci Pharmaceutical Co Ltd. The current atr is 0.30454702.

Lanzhou Foci Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartLanzhou Foci Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lanzhou Foci Pharmaceutical Co Ltd. The current obv is 143,605,173.

Lanzhou Foci Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartLanzhou Foci Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lanzhou Foci Pharmaceutical Co Ltd. The current mfi is 46.20.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Lanzhou Foci Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartLanzhou Foci Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lanzhou Foci Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lanzhou Foci Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lanzhou Foci Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.173
Ma 20Greater thanMa 507.696
Ma 50Greater thanMa 1007.645
Ma 100Greater thanMa 2008.542
OpenGreater thanClose7.150
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lanzhou Foci Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Lanzhou Foci Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lanzhou Foci Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lanzhou Foci Pharmaceutical Co Ltd

I send you an email if I find something interesting about Lanzhou Foci Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Lanzhou Foci Pharmaceutical Co Ltd.

Receive notifications about Lanzhou Foci Pharmaceutical Co Ltd in your mailbox!